The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells

The only currently available approach to early efficacy testing of tuberculosis (TB) vaccine candidates is in vivo preclinical challenge models. These typically include mice, guinea pigs and non-human primates (NHPs), which must be exposed to virulent M.tb in a ‘challenge’ experiment following vacci...

Полное описание

Библиографические подробности
Главные авторы:	Tanner, R, Hoogkamer, E, Bitencourt, J, White, A, Boot, C, Sombroek, CC, Harris, SA, O'Shea, MK, Wright, D, Wittenberg, R, Sarfas, C, Satti, I, Verreck, FAW, Sharpe, SA, Fletcher, HA, McShane, H
Формат:	Journal article
Язык:	English
Опубликовано:	F1000Research 2021

Схожие документы

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 1; peer review: 2 approved]
по: Rachel Tanner, и др.
Опубликовано: (2021-03-01)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 2; peer review: 2 approved]
по: Rachel Tanner, и др.
Опубликовано: (2021-09-01)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
по: Tanner, R, и др.
Опубликовано: (2021)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
по: Rachel Tanner, и др.
Опубликовано: (2021-01-01)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
по: Pepponi, I, и др.
Опубликовано: (2017)

The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
по: Brennan, M, и др.
Опубликовано: (2017)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
по: Tanner, R, и др.
Опубликовано: (2021)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
по: Tanner, R, и др.
Опубликовано: (2020)

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
по: Rachel Tanner, и др.
Опубликовано: (2020-01-01)

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
по: Painter, H, и др.
Опубликовано: (2024)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
по: Mcshane, H, и др.
Опубликовано: (2017)

Distinct transcriptional and anti-mycobacterial profiles of peripheral blood monocytes dependent on the ratio of monocytes: lymphocytes
по: Naranbhai, V, и др.
Опубликовано: (2015)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
по: Harris, S, и др.
Опубликовано: (2017)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
по: O'Shea, M, и др.
Опубликовано: (2018)

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model
по: Matsumiya, M, и др.
Опубликовано: (2014)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
по: Tanner, R, и др.
Опубликовано: (2017)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
по: Marsay, L, и др.
Опубликовано: (2013)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
по: Marsay, L, и др.
Опубликовано: (2013)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
по: Matthew K. O’Shea, и др.
Опубликовано: (2018-09-01)

Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients
по: Ongarj, J, и др.
Опубликовано: (2024)

Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes
по: Vivek Naranbhai, и др.
Опубликовано: (2015-11-01)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
по: Painter, H, и др.
Опубликовано: (2024)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
по: Alvarez, MPP, и др.
Опубликовано: (2024)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
по: Hannah Painter, и др.
Опубликовано: (2024-02-01)

Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection
по: Matthew K. O'Shea, и др.
Опубликовано: (2018-12-01)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
по: McNeill, E, и др.
Опубликовано: (2018)

Human hookworm infection enhances mycobacterial growth inhibition and associates with reduced risk of tuberculosis infection
по: O'Shea, M, и др.
Опубликовано: (2018)

Induction of functional specific antibodies, IgG-secreting plasmablasts and memory B cells following BCG vaccination
по: Bitencourt, J, и др.
Опубликовано: (2021)

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates
по: Peralta-Álvarez, MP, и др.
Опубликовано: (2024)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
по: Eileen McNeill, и др.
Опубликовано: (2018-12-01)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
по: Marco Polo Peralta Alvarez, и др.
Опубликовано: (2024-05-01)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
по: Fletcher, H, и др.
Опубликовано: (2013)

The characterisation of mycobacterial control profiles and underlying immune signatures in patients with latent tuberculosis infection and active disease
по: O'Shea, M
Опубликовано: (2016)

Evaluating the effect of BCG vaccination on a whole-blood mycobacterial growth inhibition assay (BACTEC MGIT)
по: Tanner, R, и др.
Опубликовано: (2011)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
по: Meyer, J, и др.
Опубликовано: (2013)

Quantitative Rapid Test for Detection and Monitoring of Active Pulmonary Tuberculosis in Nonhuman Primates
по: Zijie Zhou, и др.
Опубликовано: (2021-12-01)

A review of clinical models for the evaluation of human TB vaccines.
по: O'Shea, M, и др.
Опубликовано: (2016)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
по: Painter, H, и др.
Опубликовано: (2020)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
по: Matsumiya, M, и др.
Опубликовано: (2014)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
по: Meyer, J, и др.
Опубликовано: (2013)